Log in

3933 United Laboratories International Holdings Ltd. HKEX · Hong Kong

United Laboratories International Holdings (3933) news

United Laboratories International Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3933, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest United Laboratories International Holdings news

We have not published a story on United Laboratories International Holdings yet. When there is news, it will appear here.

Questions about United Laboratories International Holdings

What is the ticker symbol of United Laboratories International Holdings?

United Laboratories International Holdings Ltd. trades under the ticker 3933 on HKEX.

Where is United Laboratories International Holdings listed?

United Laboratories International Holdings Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:UNJ; LS:A0MUFS; OTC:ULIHF.

Which country or territory is United Laboratories International Holdings listed under?

Our directory records United Laboratories International Holdings Ltd. under Hong Kong.

What does United Laboratories International Holdings do?

Our directory classifies United Laboratories International Holdings Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of United Laboratories International Holdings?

The ISIN recorded for United Laboratories International Holdings Ltd. is KYG8813K1085.

Does aibio.space cover United Laboratories International Holdings?

aibio.space lists United Laboratories International Holdings Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to United Laboratories International Holdings?

Companies in our directory listed in the same country and business area as United Laboratories International Holdings: Wai Yuen Tong Medicine Holdings, PuraPharm Corp., Extrawell Pharmaceutical Holdings, Sino Biopharmaceutical, Regencell Bioscience Holdings, Beijing Tong Ren Tang Chinese Medicine Co..

Investor discussion: United Laboratories International Holdings

Members talk about United Laboratories International Holdings (3933). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at United Laboratories International Holdings, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. Source

  2. Financings

    Share or debt issue: PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. Source

Press releases

Headlines of United Laboratories International Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    SECOND MILESTONE PAYMENT FROM NOVO FOR EXCLUSIVE LICENSE AGREEMENT OF UBT251

  2. HKEXnews

    Notification Letter to Non-register Holder and Reply Form

  3. HKEXnews

    Notification Letter to Shareholder and Reply Form

  4. HKEXnews

    THE GROUP'S PRODUCT INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION MARKETING REGISTRATION APPLICATION BEEN ACCEPTED

  5. HKEXnews

    UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR TYPE 2 DIABETES IN CHINA

  6. HKEXnews

    UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR OVERWEIGHT OR OBESITY IN CHINA

  7. HKEXnews

    CLARIFICATION ANNOUNCEMENT TO 2026 INTERIM RESULTS ANNOUNCEMENT

  8. HKEXnews

    Interim Results Announcement For The Six Months Ended 30 June 2026

  9. HKEXnews

    PROFIT WARNING

  10. HKEXnews

    FDA APPROVAL OF IND FOR THE GROUP'S PRODUCT UBT48128 TABLETS

  11. HKEXnews

    RECEIVED MILESTONE PAYMENT FROM NOVO NORDISK FOR EXCLUSIVE LICENSE AGREEMENT OF UBT251

  12. HKEXnews

    APPROVAL FOR MARKETING OF THE GROUP'S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION

  13. HKEXnews

    APPROVAL FOR MARKETING OF THE GROUP'S PRODUCT TADALAFIL TABLETS

  14. HKEXnews

    RETIREMENT OF EXECUTIVE DIRECTOR

  15. HKEXnews

    Final dividend for the year ended 31 December 2025

  16. HKEXnews

    PAYMENT OF 2025 FINAL DIVIDEND

  17. HKEXnews

    POLL RESULTS OF THE 2026 ANNUAL GENERAL MEETING

  18. HKEXnews

    APPROVAL FOR CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL321 CAPSULES

  19. HKEXnews

    VOLUNTARY ANNOUNCEMENT PROPOSED SHARE BUY-BACK UNDER GENERAL MANDATE

  20. HKEXnews

    APPROVAL FOR CLINICAL TRIAL OF GROUP'S PRODUCT TUL108 FOR INJECTION

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3933 on TradingView.

Listing details

United Laboratories International Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3933, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
United Laboratories International Holdings Ltd.
Ticker
3933
Listing
HKEX
Country or territory
Hong Kong
Business scope
Biopharma / pharmaceutical profile checked
ISIN
KYG8813K1085
Other listed symbols
GETTEX:UNJ; LS:A0MUFS; OTC:ULIHF
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.